Progress, Potential, and Possibilities Podcast / Show

Send us Fan Mail We may be building something entirely new - a kind of digital nervous system for the planet, where satellites and AI are constantly sensing and interpreting what’s happening on Earth. Sean Donegan is the Founder and CEO of Satelytics ( https://www.satelytics.com/ ), a pioneer in applying artificial intelligence to high-resolution satellite imagery to monitor and protect critical i...

Send us Fan Mail Doctors in North America are now prescribing something you can’t buy at a pharmacy… and it’s backed by a growing body of science.  Jennie McCaffrey is the Vice President of Health & Education at the BC Parks Foundation ( https://bcparksfoundation.ca/ ), where she leads initiatives designed to connect people to nearby nature for the benefit of both human health and the planet....

Send us Fan Mail Imagine a device that can sense disease in real time… and treat it instantly. That’s the promise of Bioelectronics. Dr. Robert Spoelgen, Ph. D. is Vice President and Head of Bioelectronics at Merck KGaA Darmstadt Germany ( https://www.emdgroup.com/en/the-future-transformation/healing-power-electronics.html ), where he leads one of the company’s most forward-looking initiatives at...

Send us Fan Mail Today’s conversation sits at the intersection of one of the most ambitious - and most challenging - frontiers in modern medicine: regenerative cell therapy. For decades, the vision has been incredibly compelling - replace damaged or dying cells with healthy ones, and you could potentially restore function in diseases like macular degeneration, spinal cord injury, hearing loss, and...

Send us Fan Mail In times of crisis, innovation doesn’t slow down - it accelerates. Over the past several years, Ukraine has become globally recognized for its rapid advances in defense technology - particularly in drones and distributed manufacturing. But alongside that transformation, another revolution has been quietly taking shape: the future of medicine, built under extreme conditions. Today,...

Send us Fan Mail Today on Progress, Potential And Possibilities, we explore a different kind of breakthrough in cognitive health - not a drug, not a device, but a simple daily practice that’s quietly transforming lives. Our guest is Rob Liebreich, President and CEO of Goodwin Living ( https://goodwinliving.org/ ), an organization serving thousands of older adults across the Washington, D.C. region...

Send us Fan Mail Today’s conversation is part of a new series we’re launching — ‘Past Forward: Lessons for the Next Century.’  In this series, we examine pivotal moments, systems, and individuals from the past - not to relive them, but to better understand how they continue to shape the world we are building.  Because many of the defining forces of our time - globalized networks, technological esc...

Send us Fan Mail What if a simple blood test could detect Alzheimer’s years—maybe even decades—before symptoms ever appear? Mike Banville is the Chief Executive Officer of ALZpath ( https://alzpath.bio/ ), a company at the forefront of transforming how Alzheimer’s disease is detected and monitored through cutting-edge blood-based diagnostics. Mike is a seasoned global executive with a track record...

Send us Fan Mail There’s a revolution happening in pet health right now - where a simple stool sample can reveal disease risk, immune health, and even how long your dog might live. Dr. Bushra Schuitemaker, Ph. D. is a microbiologist, zoologist, and science leader working at the cutting edge of microbiome research, animal health, and nutrition.  Dr. Schuitemaker serves as Head of Science and Resear...

Send us Fan Mail What if the biggest barrier in healthcare today isn’t science - but stigma? Eric Foster is Chief Commercial Officer at Ardelyx ( https://ardelyx.com/ ), a biopharmaceutical company where he leads global commercialization strategy for innovative therapies addressing high-burden gastrointestinal and cardiorenal diseases.  A seasoned biotech executive with over two decades of experie...

Send us Fan Mail What if paralysis wasn’t permanent—but just a biological system we haven’t figured out how to reboot? Dr. Lior Shaltiel, Ph. D. is Chief Executive Officer of NurExone Biologic ( https://nurexone.com/ ), a biotech company pioneering a novel exosome-based platform aimed at repairing the central nervous system. Dr. Shaltiel brings a rare combination of deep scientific training and cr...

Send us Fan Mail What if most dogs aren’t dying of old age - but from losing their ability to move? Dr. Laurie McCauley, DVM, DACVSMR, CCRT, CVA, CVC is a pioneer in veterinary rehabilitation and one of the most influential figures in canine sports medicine. With over two decades at the forefront of the field, she founded the first dedicated veterinary rehabilitation clinic in the United States an...

Send us Fan Mail What if we could restore vision, communicate directly with the brain, and even extend human life—not with machines alone, but with living, engineered biology? Dr. Alan Mardinly, Ph. D. is the Chief Scientific Officer and Co-Founder of Science Corp. ( https://science.xyz/ ), a neurotechnology company developing next-generation brain interfaces and biohybrid neural implants aimed at...

Send us Fan Mail There are over 9,000 rare diseases affecting 300 million people—and yet 90% of them have no approved treatment. Why? Craig Martin is the Founder and CEO of Orphan Therapeutics Accelerator ( https://www.orphantxl.com/ ), a pioneering nonprofit launched in 2024 to advance shelved therapies for ultra-rare diseases—bringing overlooked science back to life and guiding it through approv...

Send us Fan Mail Inside a fusion reactor, you’re not just creating a star—you’re building a machine that has to survive one. Temperatures hotter than the sun, relentless neutron bombardment… and materials that slowly destroy themselves from the inside out. Daniel Clark is a nuclear engineer and fusion energy expert working at the forefront of turning fusion from a scientific pursuit into a practic...

Send us Fan Mail What if the reason we haven’t explored deep space isn’t because we can’t… but because our engines are fundamentally too slow? Richard Dinan is Founder and CEO of Pulsar Fusion ( https://pulsarfusion.com/ ) and one of the few entrepreneurs in the world not trying to bring fusion power to Earth… but to space. While most fusion startups are focused on powering cities, Richard is buil...

Send us Fan Mail What if we could build a fusion reactor that runs continuously—without the instability issues that have plagued the field for years? Brian Berzin is the Co-Founder and CEO of Thea Energy ( https://thea.energy/ ), a next-generation fusion company focused on advancing stellarator technology—one of the most promising but historically underexplored approaches to magnetic confinement f...

Send us Fan Mail Imagine treating back pain not with surgery, not with opioids—but by using your own stem cells to repair the damage at its source. Lance Alstodt is President, CEO, and Chairman of BioRestorative Therapies, Inc. ( https://biorestorative.com/ ), a publicly traded regenerative medicine company focused on developing stem cell-based therapies to treat highly prevalent conditions, inclu...

Send us Fan Mail We’re living through a golden age of rare disease breakthroughs—but for many patients, the hardest part begins after the drug is approved. Today we’re joined by two leaders from the multinational biopharmaceutical company UCB ( https://www.ucb.com/ ) who are helping reshape how the rare disease community thinks about what happens after a therapy is approved—because for many famili...

Send us Fan Mail Whether it’s a battlefield, a construction site, or a farm, the challenge is the same: how do you turn massive amounts of visual data into fast, accurate decisions? Increasingly, the answer is autonomous systems. transforming how we see the world—turning raw imagery into decisions at unprecedented speed. Bill Irby is CEO and Board Member of EagleNXT ( https://eaglenxt.com/ ), a le...

Send us Fan Mail Preventing transplant loss doesn’t just save organs—it could eliminate hospitalizations, reduce lifelong medications, and transform millions of lives. Dr. Janine Gaiha-Rohrbach, Ph. D. is a globally recognized leader in immunology and medical strategy, currently serving as Head of Global Medical Immunology at Biogen ( https://www.biogen.com/ ).  With a PhD in Immunology and Virolo...

Send us Fan Mail Pharma has spent decades building a graveyard of failed drugs — but hidden inside that data may be treatments that actually worked… for someone. Vin Singh is Founder and CEO of BullFrog AI ( https://bullfrogai.com/ ), a company working at the intersection of machine learning, causal modeling, and drug development. BullFrog is focused on a fundamental problem in biopharma — not jus...

Send us Fan Mail Bone marrow transplants have always depended on finding the right donor at the right time. But what if bone marrow could be stored, shipped, and used on demand—just like a drug? That’s exactly what Ossium Health is now showing in human clinical data. Kevin Caldwell is the Co-Founder, CEO, and President of Ossium Health ( https://ossiumhealth.com/ ), a clinical-stage bioengineering...

Send us Fan Mail Lyme disease affects hundreds of thousands of people every year—and yet we still struggle to diagnose it, treat it, and prevent it. David Walsey is a strategic biotech leader with more than two decades of experience helping public life sciences companies translate scientific innovation into market impact.  As Executive Director of the Bay Area Lyme Foundation ( https://www.bayarea...

Send us Fan Mail There’s an entire medical specialty, Physiatry, dedicated not to treating disease - but to helping patients regain their lives. And most people have never heard of it. Dr. Michael Yochelson is a Physiatrist and a nationally recognized leader in rehabilitation medicine and brain injury care ( https://shepherd.org/staff-directory/michael-yochelson/ ). Dr. Yochelson serves as the Chi...